SCHEMBL7365625

SCHEMBL7365625

CC(CS(=O)(=O)c1ccccc1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.52
HSD11B1 P28845 6/20 0.50
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
HTT P42858 1/20 0.43
HSD17B10 Q99714 1/20 0.43
APAF1 O14727 1/20 0.43
MAPT P10636 1/20 0.43
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
BCAT1 P54687 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370842 0.85 PSIP1 (0.48) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL6550974 0.84 HSD11B1 (0.49) PSIP1HSD11B1MEN1KMT2AALDH1A1
SCHEMBL8414713 0.82 POLB (0.47) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL9218545 0.82 POLB (0.47) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL27279139 0.81 HSD11B1 (0.50) PSIP1HSD11B1KMT2APOLBALDH1A1
SCHEMBL7135389 0.81 PSIP1 (0.48) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL7141503 0.81 PSIP1 (0.48) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL17697191 0.80 MMP2 (0.54) PSIP1HSD11B1MEN1KMT2AMAPT
SCHEMBL9426107 0.80 PSIP1 (0.56) PSIP1HSD11B1MEN1KMT2APOLB
SCHEMBL7724605 0.80 PSIP1 (0.56) PSIP1HSD11B1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334287-A1 NLRP3 INFLAMMASOME-INHIBITING COMPOUNDS AND THE USE THEREOF Università Degli Studi Di Torino (IT) 2024-03-13 EP disclosed
WO-2022234447-A1 NLRP3 INFLAMMASOME-INHIBITING COMPOUNDS AND THE USE THEREOF UNIVERSITA' DEGLI STUDI DI TORINO (IT) 2022-11-10 WO disclosed
CN-1158254-C 'Beta'-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors �������Ŷ���Լ��������˾ 2004-07-21 CN disclosed
US-6235928-B1 ENZYME INHIBITOR MATRIX METALLOPROTEINASE FAMILY, INCLUDING COLLAGENASE, STROMELYSIN, AND GELATINASE, THE COMPOUNDS OR PHARMACEUTICAL COMPOSITIONS PHARMACIA & UPJOHN COMPANY 2001-05-22 US disclosed
CN-1230177-A 'Beta'-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors UPJOHN CO (US) 1999-09-29 CN disclosed
EP-0932598-A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 1999-08-04 EP disclosed
EP-0929519-A1 $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1999-07-21 EP disclosed
US-5847153-A β-sulfonyl hydroxamic acids PHARMACIA & UPJOHN COMPANY (US) 1998-12-08 US disclosed
WO-1998016502-A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 1998-04-23 WO disclosed
WO-1998013340-A1 β-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1998-04-02 WO disclosed